A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.

Clinical trial NCT02759419 · COMPLETED

Trial details

NCT number: NCT02759419
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hypertension, Pulmonary

Start date: 2016-06-16
Primary completion: 2025-09-15
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.